Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,112.20 -206.04 -1.35%
S&P 500 1,628.93 -22.88 -1.39%
Nasdaq 3,443.20 -38.98 -1.12%
Ticker Volume Price Price Delta
STOXX 50 2,683.98 -16.95 -0.63%
FTSE 100 6,348.82 -25.39 -0.40%
DAX 8,197.08 -32.43 -0.39%
Ticker Volume Price Price Delta
Nikkei 13,245.20 +237.94 1.83%
Hang Seng 20,986.90 -238.99 -1.13%
S&P/ASX 200 4,861.38 +47.03 0.98%
  • Fund Type: SICAV
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

Dexia Equities L - Biotechnology

+ Add to Watchlist

XUJ4:GR

219.7100 EUR 0.7200 0.33%

As of 14:55:10 ET on 06/19/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Dexia Equities L - Biotechnology (XUJ4)

Open: 222.0200 High - Low: 224.1050 - 219.4850 Primary Exchange: Berlin
Volume: 22 52-Week Range: 163.0000 - 241.1550 Beta vs BTK: 0.6798

ETF Chart for XUJ4

No chart data available.
  • XUJ4:GR 221.9400
  • 1D
  • 1M
  • 1Y
220.4300
Interactive XUJ4 Chart

Previous Close

Fund Profile & Information for XUJ4

Dexia Equities L - Biotechnology is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests in global biotechnology stocks. Because the sector is currently experiencing the highest growth in the U.S., at least two-thirds of the Fund's assets will be invested in U.S. biotechnology stocks.

Inception Date: 2000-04-06 Telephone: 352-254-3431
Managers: RUDI VAN DEN EYNDE
Web Site: www.dexia-am.com

Fundamentals for XUJ4

NAV -
Assets (M) (on 2013-06-18) 384.2431
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for XUJ4

No dividends reported

Performance for XUJ4

1-Month -5.80% 1-Year +33.41%
3-Month +7.94% 3-Year +21.25%
Year To Date +29.03% 5-Year +24.83%
Expense Ratio 1.77

Top Fund Holdings for XUJ4

Filing Date: 04/30/2013
Name Position Value % of Total
Gilead Sciences Inc 480,000 24,307,200 7.021%
Amgen Inc 228,000 23,759,880 6.863%
Biogen Idec Inc 106,000 23,206,580 6.703%
Regeneron Pharmaceuticals Inc 78,000 16,780,920 4.847%
Celgene Corp 124,200 14,664,294 4.236%
Alexion Pharmaceuticals Inc 120,000 11,760,000 3.397%
H Lundbeck A/S 483,000 9,668,614 2.793%
Onyx Pharmaceuticals Inc 100,000 9,480,000 2.738%
Vertex Pharmaceuticals Inc 122,000 9,372,040 2.707%
Ablynx NV 820,000 6,918,963 1.998%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil